The company said affordability and predictable pricing drive demand, with its LillyDirect platform adding over 1 million users in 2025.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Eli Lilly Stock Notches Best Day In 9 Months: Touts $50 Medicare For Obesity Drugs As ‘Compelling Value Proposition’ After Q4 Beat
The company said affordability and predictable pricing drive demand, with its LillyDirect platform adding over 1 million users in 2025.